-
1دورية أكاديمية
المؤلفون: Bourdin, Arnaud, Molinari, Nicolas
المساهمون: Physiologie & médecine expérimentale du Cœur et des Muscles U 1046 (PhyMedExp), Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Université de Montpellier (UM), Centre Hospitalier Régional Universitaire Montpellier (CHRU Montpellier), Institut Montpelliérain Alexander Grothendieck (IMAG), Centre National de la Recherche Scientifique (CNRS)-Université de Montpellier (UM)
المصدر: ISSN: 0954-6111.
مصطلحات موضوعية: Benralizumab, Indirect treatment comparison, Matching-adjusted indirect comparison, Mepolizumab, Severe eosinophilic asthma, Dupilumab, [SDV.IMM.ALL]Life Sciences [q-bio]/Immunology/Allergology, [SDV.MHEP.PSR]Life Sciences [q-bio]/Human health and pathology/Pulmonology and respiratory tract, [SDV.IMM.IMM]Life Sciences [q-bio]/Immunology/Immunotherapy, [STAT.ME]Statistics [stat]/Methodology [stat.ME]
العلاقة: hal-03548301; https://hal.science/hal-03548301Test; https://hal.science/hal-03548301/documentTest; https://hal.science/hal-03548301/file/2022%20Bourdin%20%20Molinari%20%20Non%20Optimal.pdfTest
الإتاحة: https://doi.org/10.1016/j.rmed.2020.105999Test
https://hal.science/hal-03548301Test
https://hal.science/hal-03548301/documentTest
https://hal.science/hal-03548301/file/2022%20Bourdin%20%20Molinari%20%20Non%20Optimal.pdfTest -
2دورية أكاديمية
المؤلفون: Bourdin, Arnaud, Molinari, Nicolas
المساهمون: Physiologie & médecine expérimentale du Cœur et des Muscles U 1046 (PhyMedExp), Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Université de Montpellier (UM), Centre Hospitalier Régional Universitaire Montpellier (CHRU Montpellier), Institut Montpelliérain Alexander Grothendieck (IMAG), Centre National de la Recherche Scientifique (CNRS)-Université de Montpellier (UM)
المصدر: ISSN: 0954-6111.
مصطلحات موضوعية: Benralizumab, Indirect treatment comparison, Matching-adjusted indirect comparison, Mepolizumab, Severe eosinophilic asthma, Dupilumab, [SDV.IMM.ALL]Life Sciences [q-bio]/Immunology/Allergology, [SDV.MHEP.PSR]Life Sciences [q-bio]/Human health and pathology/Pulmonology and respiratory tract, [SDV.IMM.IMM]Life Sciences [q-bio]/Immunology/Immunotherapy, [STAT.ME]Statistics [stat]/Methodology [stat.ME]
العلاقة: hal-03548301; https://hal.science/hal-03548301Test; https://hal.science/hal-03548301/documentTest; https://hal.science/hal-03548301/file/2022%20Bourdin%20%20Molinari%20%20Non%20Optimal.pdfTest
الإتاحة: https://doi.org/10.1016/j.rmed.2020.105999Test
https://hal.science/hal-03548301Test
https://hal.science/hal-03548301/documentTest
https://hal.science/hal-03548301/file/2022%20Bourdin%20%20Molinari%20%20Non%20Optimal.pdfTest -
3دورية أكاديمية
المؤلفون: Bourdin, Arnaud, Molinari, Nicolas
المساهمون: Physiologie & médecine expérimentale du Cœur et des Muscles U 1046 (PhyMedExp), Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Université de Montpellier (UM), Centre Hospitalier Régional Universitaire Montpellier (CHRU Montpellier), Institut Montpelliérain Alexander Grothendieck (IMAG), Centre National de la Recherche Scientifique (CNRS)-Université de Montpellier (UM)
المصدر: ISSN: 0954-6111.
مصطلحات موضوعية: Benralizumab, Indirect treatment comparison, Matching-adjusted indirect comparison, Mepolizumab, Severe eosinophilic asthma, Dupilumab, [SDV.IMM.ALL]Life Sciences [q-bio]/Immunology/Allergology, [SDV.MHEP.PSR]Life Sciences [q-bio]/Human health and pathology/Pulmonology and respiratory tract, [SDV.IMM.IMM]Life Sciences [q-bio]/Immunology/Immunotherapy, [STAT.ME]Statistics [stat]/Methodology [stat.ME]
العلاقة: hal-03548301; https://hal.science/hal-03548301Test; https://hal.science/hal-03548301/documentTest; https://hal.science/hal-03548301/file/2022%20Bourdin%20%20Molinari%20%20Non%20Optimal.pdfTest
الإتاحة: https://doi.org/10.1016/j.rmed.2020.105999Test
https://hal.science/hal-03548301Test
https://hal.science/hal-03548301/documentTest
https://hal.science/hal-03548301/file/2022%20Bourdin%20%20Molinari%20%20Non%20Optimal.pdfTest
